GSK submits diabetes drug albiglutide to FDA review

01/14/2013 | Reuters

GlaxoSmithKline has applied to the FDA for approval to market albiglutide, an experimental weekly drug for diabetes. Albiglutide belongs to a class of drugs called GLP-1 agonists that includes Novo Nordisk's Victoza. GSK plans to submit the drug for approval in Europe as well.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR